Apyx Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Apyx Medical Corporation income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue48.1052.3544.5148.5227.7128.2416.61
Cost of Revenue18.7418.5915.3814.9210.219.145.78
Gross Profit29.3633.7629.1333.6017.5019.0910.83
Operating Expenses
Research & Development5.085.444.504.323.923.732.55
Selling, General & Administrative43.1329.2329.5343.7333.6722.2121.81
Operating Expenses48.2153.7152.6948.0537.5940.3124.36
Operating Income-18.85-17.26-23.56-14.45-20.08-21.22-13.54
Other Income/Expense
Interest Income1.610.920.160.010.240.000.62
Interest Expense5.91-2.48-0.020.01-0.050.000.10
Other Income/Expense-0.162.470.51-0.370.48-1.03-1.67
Income
Income Before Tax-23.31-21.28-22.91-14.82-19.41-19.84-14.69
Income Tax Expense0.25-2.430.370.38-7.50-0.13-3.91
Net Income-23.46-18.71-23.18-15.17-11.90-19.7162.72
Net Income - Continuous Operations-23.56-18.85-23.28-15.200.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-16.80-20.59-22.01-13.91-19.20-19.07-13.92
EBIT-17.40-21.28-22.90-14.81-20.08-19.83-14.59
Depreciation & Amortization0.600.700.700.900.89-0.700.00
Earnings Per Share
Basic EPS-1.00-1.00-1.00---1.002.00
Diluted EPS-1.00-1.00-1.00---1.002.00
Basic Shares Outstanding35.5434.6234.5234.3334.2134.0733.19
Diluted Shares Outstanding35.5434.6234.5234.3334.2134.0734.37